# Femasys Inc: filings

FEMY · Nasdaq · CIK 1339005 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/femy.md) · [Financials](/companies/femy/financials.md) · [Filings](/companies/femy/filings.md) · [Insiders](/companies/femy/insiders.md)

## Reports and events: 137 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 98, 4 74, 3 23, 10-Q 16, D 15, CORRESP 12, 424B3 9, EFFECT 8, S-8 8, UPLOAD 8, DEF 14A 7, SCHEDULE 13G 6, 10-K 5, S-3 5, DEFA14A 4, 10-K/A 3, 424B5 3, ARS 3, PRE 14A 3, S-1 3, S-1/A 3, 3/A 2, D/A 2, DRS 2, DRSLTR 2, SCHEDULE 13G/A 2, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS/A 1, S-3/A 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-17 | 20:30 ET | [SCHEDULE 13D](/filings/0001104659-26-097888.md) | Ownership report, active investor | 0001104659-26-097888 |
| 2026-08-14 | 20:28 ET | [10-Q](/filings/0001140361-26-033157.md) | Quarterly report, period 2026-06-30 | 0001140361-26-033157 |
| 2026-08-14 | 20:11 ET | [8-K](/filings/0001140361-26-033145.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-033145 |
| 2026-08-11 | 20:40 ET | [8-K](/filings/0001140361-26-032247.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-26-032247 |
| 2026-06-24 | 20:05 ET | [8-K](/filings/0001140361-26-026239.md) | 5.07 Shareholder vote results | 0001140361-26-026239 |
| 2026-06-24 | 13:35 ET | [8-K](/filings/0001140361-26-026169.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-026169 |
| 2026-06-05 | 20:06 ET | [8-K](/filings/0001140361-26-024265.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-26-024265 |
| 2026-06-04 | 13:00 ET | [8-K](/filings/0001140361-26-023955.md) | 7.01 Regulation FD disclosure | 0001140361-26-023955 |
| 2026-05-13 | 20:48 ET | [8-K](/filings/0001140361-26-021081.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-021081 |
| 2026-05-08 | 20:45 ET | [10-Q](/filings/0001140361-26-020115.md) | Quarterly report, period 2026-03-31 | 0001140361-26-020115 |
| 2026-05-08 | 20:32 ET | [8-K](/filings/0001140361-26-020059.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-020059 |
| 2026-04-30 | 20:48 ET | [DEF 14A](/filings/0001140361-26-018246.md) | Proxy statement, period 2026-06-24 | 0001140361-26-018246 |
| 2026-04-29 | 20:05 ET | [8-K](/filings/0001140361-26-017805.md) | 5.07 Shareholder vote results | 0001140361-26-017805 |
| 2026-04-06 | 20:01 ET | [DEF 14A](/filings/0001140361-26-013332.md) | Proxy statement, period 2026-04-29 | 0001140361-26-013332 |
| 2026-04-01 | 13:13 ET | [8-K](/filings/0001140361-26-012538.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-012538 |
| 2026-03-31 | 21:04 ET | [10-K](/filings/0001140361-26-012375.md) | Annual report, period 2025-12-31 | 0001140361-26-012375 |
| 2026-03-31 | 20:18 ET | [8-K](/filings/0001140361-26-012346.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-012346 |
| 2026-03-20 | 21:16 ET | [8-K](/filings/0001140361-26-010591.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-010591 |
| 2026-01-15 | 14:15 ET | [8-K](/filings/0001140361-26-001268.md) | 3.01 Delisting notice | 0001140361-26-001268 |
| 2025-12-23 | 21:07 ET | [8-K](/filings/0001140361-25-046546.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-046546 |
| 2025-12-18 | 14:27 ET | [8-K](/filings/0001140361-25-045950.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-045950 |
| 2025-11-14 | 21:13 ET | [10-Q](/filings/0001140361-25-042308.md) | Quarterly report, period 2025-09-30 | 0001140361-25-042308 |
| 2025-11-14 | 21:09 ET | [8-K](/filings/0001140361-25-042304.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-042304 |
| 2025-11-10 | 14:22 ET | [8-K](/filings/0001140361-25-041293.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-041293 |
| 2025-11-07 | 22:08 ET | [8-K](/filings/0001140361-25-041180.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-25-041180 |
| 2025-11-03 | 14:19 ET | [8-K](/filings/0001140361-25-040104.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-040104 |
| 2025-10-21 | 13:16 ET | [8-K](/filings/0001140361-25-038733.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001140361-25-038733 |
| 2025-10-17 | 21:15 ET | [8-K](/filings/0001140361-25-038516.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-038516 |
| 2025-08-27 | 01:34 ET | [8-K](/filings/0001140361-25-032806.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-25-032806 |
| 2025-08-21 | 21:20 ET | [S-1/A](/filings/0001140361-25-032230.md) | Registration statement, amended | 0001140361-25-032230 |
| 2025-08-20 | 13:16 ET | [8-K](/filings/0001140361-25-032014.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-032014 |
| 2025-08-20 | 01:56 ET | [S-1](/filings/0001140361-25-031990.md) | Registration statement | 0001140361-25-031990 |
| 2025-08-08 | 20:16 ET | [10-Q](/filings/0001140361-25-029864.md) | Quarterly report, period 2025-06-30 | 0001140361-25-029864 |
| 2025-08-08 | 20:11 ET | [8-K](/filings/0001140361-25-029860.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-029860 |
| 2025-08-06 | 13:20 ET | [8-K](/filings/0001140361-25-029065.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-029065 |
| 2025-07-18 | 21:16 ET | [8-K](/filings/0001140361-25-026431.md) | 3.01 Delisting notice | 0001140361-25-026431 |
| 2025-07-03 | 21:22 ET | [8-K](/filings/0001140361-25-024878.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-25-024878 |
| 2025-07-01 | 13:20 ET | [8-K](/filings/0001140361-25-024313.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-024313 |
| 2025-06-25 | 20:01 ET | [8-K](/filings/0001140361-25-023642.md) | 5.07 Shareholder vote results | 0001140361-25-023642 |
| 2025-06-25 | 13:24 ET | [8-K](/filings/0001140361-25-023561.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-023561 |
| 2025-06-17 | 13:22 ET | [8-K](/filings/0001140361-25-022762.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-022762 |
| 2025-06-02 | 11:29 ET | [8-K](/filings/0001140361-25-021030.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-25-021030 |
| 2025-05-23 | 21:15 ET | [8-K](/filings/0001140361-25-020363.md) | 3.01 Delisting notice | 0001140361-25-020363 |
| 2025-05-08 | 21:15 ET | [10-Q](/filings/0001140361-25-017985.md) | Quarterly report, period 2025-03-31 | 0001140361-25-017985 |
| 2025-05-08 | 21:05 ET | [8-K](/filings/0001140361-25-017983.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-017983 |
| 2025-04-28 | 20:32 ET | [DEF 14A](/filings/0001140361-25-016047.md) | Proxy statement, period 2025-06-25 | 0001140361-25-016047 |
| 2025-03-27 | 13:29 ET | [10-K](/filings/0001140361-25-010598.md) | Annual report, period 2024-12-31 | 0001140361-25-010598 |
| 2025-03-27 | 13:20 ET | [8-K](/filings/0001140361-25-010595.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-010595 |
| 2025-03-18 | 13:27 ET | [8-K](/filings/0001140361-25-009177.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-009177 |
| 2025-03-13 | 12:45 ET | [8-K](/filings/0001140361-25-008559.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-008559 |

Page 1 of 3. [Older](/companies/femy/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.